J.Henderson Gl.Life Sciences F.I2 H/ IE00BMXMTZ48 /
| NAV20/05/2024 | Chg.+0.0500 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 12.0700HKD | +0.42% | reinvestment | Equity | Janus Henderson Inv. ▶ |
Funds documents
| Date | Document | Year | Language | Filesize |
|---|---|---|---|---|
| 21/05/2024 | Public WebStation Live Factsheet | 2024 | English | - |
| 20/03/2024 | PRIIP Key Information Document | 2024 | English | 116.24 KB |
| 31/12/2023 | Account statment | 2023 | English | 2,273.53 KB |
| 29/12/2023 | Prospectus | 2023 | English | 4,732.84 KB |
| 29/12/2023 | Prospectus | 2023 | German | 4,893.26 KB |
| 30/06/2023 | Semi-annual report | 2023 | English | 6,997.79 KB |
| 31/12/2022 | Account statment | 2022 | German | 3,512.75 KB |
| 01/10/2022 | Key Investor Information | 2022 | English | 133.11 KB |
| 30/06/2022 | Semi-annual report | 2022 | German | 4,631.53 KB |
